About: Pharmacokinetics, immunogenicity and safety of bivatuzumab mertansine, a novel CD44v6-targeting immunoconjugate, in patients with squamous cell carcinoma of the head and neck

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Pharmacokinetics, immunogenicity and safety of bivatuzumab mertansine, a novel CD44v6-targeting immunoconjugate, in patients with squamous cell carcinoma of the head and neck Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 April 2007

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована у квітні 2007 (uk) im April 2007 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu n'abril de 2007 (ast) scientific article published on 01 April 2007 (en)
publication date	wds:Q79857933-01B856AD-A3C2-435E-ABA2-3D6FFA8BC661
publication date	2007-04-01 00:00:00Z (xsd:dateTime)
author name string	wds:Q79857933-0C859AD3-D05F-402D-98E9-D4E23FD8D880 wds:Q79857933-1E0F1D01-C03F-47AA-B8E6-B5D33235E402 wds:Q79857933-46099EDD-022A-4976-BA8F-B68659B314D2 wds:Q79857933-602B6005-BAC2-4AC4-98A5-284629457852 wds:Q79857933-71229FCE-FCE6-45F5-A43E-5ED429177DB1 wds:Q79857933-851BCEED-B31A-448E-90A4-F625E567941C wds:Q79857933-91666AC8-486E-414F-9381-84EDFF888565 wds:Q79857933-AEE1DCD3-95F1-4C9D-AEBE-650040E76015 wds:Q79857933-CD63EA99-8B93-4130-8E69-122442D40FC9 wds:Q79857933-F2E33CC6-8A6D-4CC2-90A9-4ABAA0A94289
author name string	Alexander Staab Herbert Riechelmann Charlotte Kloft Alexander Sauter Silke Gronau Karl Hoermann Carsten Schroen Felix Bogeschdorfer Thomas Erhardt Wolfram Golze
rdfs:label	Pharmacokinetics, immunogenicity and safety of bivatuzumab mertansine, a novel CD44v6-targeting immunoconjugate, in patients with squamous cell carcinoma of the head and neck (en) Pharmacokinetics, immunogenicity and safety of bivatuzumab mertansine, a novel CD44v6-targeting immunoconjugate, in patients with squamous cell carcinoma of the head and neck (nl)
skos:prefLabel	Pharmacokinetics, immunogenicity and safety of bivatuzumab mertansine, a novel CD44v6-targeting immunoconjugate, in patients with squamous cell carcinoma of the head and neck (en) Pharmacokinetics, immunogenicity and safety of bivatuzumab mertansine, a novel CD44v6-targeting immunoconjugate, in patients with squamous cell carcinoma of the head and neck (nl)
name	Pharmacokinetics, immunogenicity and safety of bivatuzumab mertansine, a novel CD44v6-targeting immunoconjugate, in patients with squamous cell carcinoma of the head and neck (en) Pharmacokinetics, immunogenicity and safety of bivatuzumab mertansine, a novel CD44v6-targeting immunoconjugate, in patients with squamous cell carcinoma of the head and neck (nl)
title	wds:Q79857933-A97E308D-4A0F-4781-8ACE-F80F80BC7377
title	Pharmacokinetics, immunogenicity and safety of bivatuzumab mertansine, a novel CD44v6-targeting immunoconjugate, in patients with squamous cell carcinoma of the head and neck (en)
page(s)	wds:Q79857933-0ABEF362-26E2-4024-8ABB-649629B12293
page(s)	927-935
instance of	wds:Q79857933-51E85514-B83D-4D77-8FC6-1425A04E92DD
instance of	scholarly article
main subject	wds:Q79857933-18AC7EC4-B3DA-42B1-A241-18916EB062A3 wds:Q79857933-5D65EE57-A8B2-4A1F-AD05-E995A1AF36E5
main subject	pharmacokinetics head and neck squamous cell carcinoma
PubMed ID	wds:Q79857933-4BE55B54-40A2-4BCD-A8CD-A8D5D2266758
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/17332932
PubMed ID	17332932
published in	wds:Q79857933-B4B7BF86-DB2D-4F05-BE8F-1AD5F74F577A
published in	International Journal of Oncology
issue	wds:Q79857933-A993333C-DEA3-40CB-AE5B-6756A588C7EF
volume	wds:Q79857933-64C2A27D-C2E1-4E6D-A60C-4836EA66C2ED
issue	4
volume	30
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q79857933
is cites work of	Targeted therapy in head and neck cancer Comparative clinical pharmacokinetics of antibody-drug conjugates in first-in-human Phase 1 studies Anticancer therapeutics: targeting macromolecules and nanocarriers to hyaluronan or CD44, a hyaluronan receptor Lymphatic metastasis in breast cancer: importance and new insights into cellular and molecular mechanisms Interactions between Hyaluronan and Its Receptors (CD44, RHAMM) Regulate the Activities of Inflammation and Cancer Hyaluronan-CD44 interactions as potential targets for cancer therapy. The Importance of CD44 as a Stem Cell Biomarker and Therapeutic Target in Cancer Immunological treatment options for locoregionally advanced head and neck squamous cell carcinoma Effects of antibody, drug and linker on the preclinical and clinical toxicities of antibody-drug conjugates First-in-human phase I clinical trial of RG7356, an anti-CD44 humanized antibody, in patients with advanced, CD44-expressing solid tumors. Antibody structure and engineering considerations for the design and function of Antibody Drug Conjugates (ADCs). Syngeneic Mouse Models of Oral Cancer Are Effectively Targeted by Anti-CD44-Based NIR-PIT. Systemic therapy strategies for head-neck carcinomas: Current status Selective killing of breast cancer cells expressing activated CD44 using CD44 ligand-coated nanoparticles in vitro and in vivo CD44v6-Targeted Imaging of Head and Neck Squamous Cell Carcinoma: Antibody-Based Approaches Immunotherapy of head and neck cancer. Current developments A unified model of the hierarchical and stochastic theories of gastric cancer
is cites work of	wds:Q26830923-FAF3CDB1-9456-4EE0-9F0E-87A355EFF876 wds:Q37988981-B2E37DB5-CADA-4FC6-AF2B-F80CE1EA9430 wds:Q52704026-51453422-B1DC-4A69-B66A-EFF4CABE352F wds:Q36529843-08E0A0FF-323D-4610-AC1C-44B42E26328E wds:Q38798481-9DA82A5B-1AEB-4603-9FC8-6E4C93E453E6 wds:Q36994267-486E83E3-F58D-44D2-BB3B-47EE0C7A83CD wds:Q45770749-9692405B-21E6-4BE6-BEB3-E7B72EF7882D wds:Q26747319-07EAC74F-D6E4-43FE-9530-AB2AA8ACFD4A wds:Q34181954-F4CD8D21-79D1-4ADC-AC78-CC92B995F378 wds:Q37188974-3C998154-A953-4D7F-A8BF-FBAFFD021A4B wds:Q33577624-86025C20-1E84-4AC5-8787-703F7EDC2349 wds:Q27021261-6151E45D-636B-48FD-A8D2-F4C87B842B37 wds:Q35194441-C7D927B5-A1E1-48F9-ABFE-C821121F3EDC wds:Q47964921-03946EC0-05EB-4E3D-BDFB-1B1E33A65A40 wds:Q43376023-856FB080-EB71-444F-B9FF-298C52A8D1F3 wds:Q36021000-7F584751-F8DE-4780-825D-F12949111000 wds:Q40093426-E85B5582-5B67-4DF0-9592-4013DE948A1F

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 183 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software